Fact checked by Nick Blackmer Cases of respiratory syncytial virus (RSV) have peaked in many areas of the United States, ...

This lack of testing amplifies the misdiagnosis of RSV, as its symptoms are so similar to other, more common respiratory viruses like flu. A lack of recognition can also be seen in older adults ...

Researchers performed a retrospective case-control study using data from a large US healthcare network to evaluate the effectiveness of the RSVpreF vaccine in protecting older adults against RSV ...

The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is ...

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

U.S. approved the RSVpreF vaccine for adults 60 years and older in 2023, recommending it only based on individual’s decisions ...

Since 2023, vaccines are now available and are highly recommended, especially for older adults. Respiratory syncytial virus (RSV) is a common virus that causes mild to severe respiratory infections.

The all-cause hospitalization rate at 28 days is high among adults with outpatient medically attended RSV infections.

In the Lehigh Valley, cases of the flu and RSV are particularly prevalent compared with many other parts of the state.

For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.

The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...

Bon Secours and Prisma Health are implementing new visitor restrictions as cases of influenza and respiratory illnesses rise ...